Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease

Robertus van Aalst, Ellyn M. Russo, Nabin Neupane, Salaheddin M. Mahmud, Vincent Mor, Jan Wilschut, Ayman Chit, Maarten Postma, Yinong Young-Xu
2019 Vaccine  
To compare the economic impact of high-dose trivalent (HD) versus standard-dose trivalent (SD) influenza vaccination on direct medical costs for cardio-respiratory hospitalizations in adults aged 65 years or older enrolled in the United States (US) Veteran's Health Administration (VHA).
doi:10.1016/j.vaccine.2019.06.066 pmid:31262590 fatcat:u6da2dqwlfeenhbov2ak2aorpu